BioCardia, Inc.
NASDAQBioCardia heads into the post-earnings stretch with short sellers in retreat and a CEO who keeps buying despite a week of heavy selling pressure. The week was shaped by Thursday's Q1 print. BioCardia missed the EPS estimate by $0.04, reporting $(0.21) against a $(0.17) consensus. The stock dropped 7.3% on the day and closed Friday at $1.01 — down 9% on the week and 14% over the…
BCDA short interest surges 189% in one week to 4.2% of float, driven by volatile price swings and heavy short buildup.
Snapshot as of 29 Jun 2026
BioCardia heads into the post-earnings stretch with short sellers in retreat and a CEO who keeps buying despite a week of heavy selling pressure. The week was shaped by Thursday's Q1 print. BioCardia missed the EPS…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for BCDA — free to start on ORTEX.
Sign up for free →Open BCDA on ORTEXPulses are triggered by ORTEX's live data feeds. The full signal history, thresholds, and alerts are on ORTEX.
Live BCDA data →